Infinity Primary Care PLLC 37595 7 Mile Rd STE 210, Livonia, MI 48152 7344327591 (phone), 7348535698 (fax)
Education:
Medical School St. George's University School of Medicine, St. George's, Greneda Graduated: 2012
Conditions:
Acute Sinusitis
Languages:
English
Description:
Dr. Michaels graduated from the St. George's University School of Medicine, St. George's, Greneda in 2012. He works in Livonia, MI and specializes in Family Medicine. Dr. Michaels is affiliated with Providence Hospital and St Mary Mercy Livonia Hospital.
Mark Leo Michaels - Encino CA, US Thomas C. Boone - Newbury Park CA, US Rohini Deshpande - Camarillo CA, US Yue-Sheng Li - Thousand Oaks CA, US Huiquan Han - Thousand Oaks CA, US
The present invention provides stabilized activin IIB receptor polypeptides and proteins capable of binding and inhibiting the activities of activin A, myostatin, or GDF-11. The present invention also provides polynucleotides, vectors and host cells capable of producing the stabilized polypeptides and proteins. Compositions and methods for treating muscle-wasting diseases and metabolic disorders are also provided.
Mutants Of The Green Fluorescent Protein Having Improved Fluorescent Properties At 37.Degree.
The present invention relates to mutants of the green fluorescent protein having improved fluorescent properties at 37. degree. C. The mutants provide for improved methods of monitoring gene expression, e. g. , for use as cell markers or protein expression indicators in prokaryotic and, especially, eucaryotic systems where the standard physiological temperature is 37. degree. C.
Engineered Nrg-1 Variants With Improved Selectivity Toward Erbb4 But Not Against Erbb3
- Thousand Oaks CA, US Zhi LIU - Shoreline WA, US TaeWeon LEE - Palo Alto CA, US Mark L. MICHAELS - Encino CA, US Zhulun WANG - Palo Alto CA, US
International Classification:
C07K 14/485 A61P 9/10
Abstract:
The present invention relates to engineered neuregulin-1 variants that selectively activate ErbB4 receptors but do not activate ErbB3 receptors. The invention also provides methods for using such variants to treat heart failure.
- Thousand Oaks CA, US Irwin CHEN - Los Angeles CA, US Su CHONG - Oxnard CA, US Bryna FUCHSLOCHER - Thousand Oaks CA, US Kevin GRAHAM - Thousand Oaks CA, US Agnes Eva HAMBURGER - Newbury Park CA, US Mark Leo MICHAELS - Encino CA, US Christopher MOHR - Newbury Park CA, US Derek E. PIPER - Santa Clara CA, US Kenneth William WALKER - Newbury Park CA, US Zhulun WANG - Los Altos CA, US Cen XU - Newbury Park CA, US
Assignee:
AMGEN INC. - Thousand Oaks CA
International Classification:
C07K 16/18 C07K 16/28 A61P 25/06 A61K 38/22
Abstract:
The present invention relates to neutralizing antibodies of the human pituitary adenylate cyclase activating polypeptide type I receptor (PAC1) and pharmaceutical compositions comprising such antibodies. Methods of treating or preventing headache conditions, such as migraine and cluster headache, using the neutralizing antibodies are also described.
- Thousand Oaks CA, US Martin J. Pentony - Seattle WA, US Luis G. Borges - Redwood City CA, US Mark L. Michaels - Encino CA, US
International Classification:
C07K 16/46 C07K 16/30 C07K 16/28 C07K 16/32
Abstract:
Provided herein are heterodimeric bispecific antibodies that can mediate cytolysis of a target cell by an immune effector cell, nucleic acids encoding such antibodies, methods of making such antibodies, and methods of using such antibodies. These antibodies comprise two different polypeptide chains, each comprising two immunoglobulin variable regions and, optionally, a half life-extending moiety.
- Thousand Oaks CA, US Irwin CHEN - Los Angeles CA, US Su CHONG - Oxnard CA, US Bryna FUCHSLOCHER - Thousand Oaks CA, US Kevin GRAHAM - Thousand Oaks CA, US Agnes Eva HAMBURGER - Newbury Park CA, US Mark Leo MICHAELS - Encino CA, US Christopher MOHR - Newbury Park CA, US Derek E. PIPER - Santa Clara CA, US Kenneth William WALKER - Newbury Park CA, US Zhulun WANG - Palo Alto CA, US Cen XU - Newbury Park CA, US
Assignee:
AMGEN INC. - Thousand Oaks CA
International Classification:
C07K 16/18 C07K 16/28 A61P 25/06 A61K 38/22
Abstract:
The present invention relates to neutralizing antibodies of the human pituitary adenylate cyclase activating polypeptide type I receptor (PAC1) and pharmaceutical compositions comprising such antibodies. Methods of treating or preventing headache conditions, such as migraine and cluster headache, using the neutralizing antibodies are also described.
- Thousand Oaks CA, US Mark Leo MICHAELS - Encino CA, US Thomas Charles BOONE - Newbury Park CA, US Rohini DESHPANDE - Camarillo CA, US Yue-Sheng LI - Cambridge MA, US Huiquan HAN - Thousand Oaks CA, US
International Classification:
C07K 14/71 C07K 14/495
Abstract:
The present invention provides stabilized activin IIB receptor polypeptides and proteins capable of binding and inhibiting the activities of activin A, myostatin, or GDF-11. The present invention also provides polynucleotides, vectors and host cells capable of producing the stabilized polypeptides and proteins. Compositions and methods for treating muscle-wasting diseases and metabolic disorders are also provided.
- Thousand Oaks CA, US Irwin CHEN - Los Angeles CA, US Su CHONG - Oxnard CA, US Bryna FUCHSLOCHER - Thousand Oaks CA, US Kevin GRAHAM - Thousand Oaks CA, US Agnes Eva HAMBURGER - Newbury Park CA, US Mark Leo MICHAELS - Encino CA, US Christopher MOHR - Newbury Park CA, US Derek E. PIPER - Santa Clara CA, US Kenneth William WALKER - Newbury Park CA, US Zhulun WANG - Palo Alto CA, US Cen XU - Newbury Park CA, US
Assignee:
AMGEN INC. - Thousand Oaks CA
International Classification:
C07K 16/18 A61P 25/06 A61K 38/22
Abstract:
The present invention relates to neutralizing antibodies of the human pituitary adenylate cyclase activating polypeptide type I receptor (PAC1) and pharmaceutical compositions comprising such antibodies. Methods of treating or preventing headache conditions, such as migraine and cluster headache, using the neutralizing antibodies are also described.
Name / Title
Company / Classification
Phones & Addresses
Mark Michaels Partner
Centre Radio Broadcasting Stations
One Chase Manhattan Plaza, New York, NY 10005
Mark Michaels Human Resources Assistant
Vulcan Inc. Real Estate Agents and Managers
505 5Th Ave S Ste 900, Seattle, WA 98104
Mark Michaels Principal
Vision Psychological Health Practitioner's Office
332 Claremont Ave, Long Beach, CA 90803
Mark Michaels Human Resources Assistant
Vulcan, Inc. Executive Office · Investment Advice
505 5 Ave S SUITE 900, Seattle, WA 98104 2063422000, 2063423000, 2063422235
Mark H. Michaels Allied Health Professional, Psychologist
Metropolitan Health Medical Group Medical Doctor's Office
3540 Wilshire Blvd, Los Angeles, CA 90010 2134803191
Customer Service Powerpoint Sales Microsoft Excel Teaching Leadership Windows English Management Microsoft Office Project Management Process Improvement Microsoft Word Research Outlook Operations Management
Bev Babin, Dee Plaisance, Anne Leblanc, Wade Murphy, Beverly Babin, Larry Twiner, Brenda Bourgeois, Colby Laplace, Floyd Sanchez, Wesley Arnold, Russell Leblanc